Intranet
Solène Desmée | IAME
Solène Desmée - Former member -

Publications

Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data

2024

DOI

PubMed

Copy reference

CPT: pharmacometrics & systems pharmacology

Pitoy A et al.Pitoy A, Desmée S, Riglet F, Thai HT, Klippel Z, Semiond D, Veyrat-Follet C, Bertrand J

Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancer

2023

DOI

PubMed

Copy reference

Biometrics

Kerioui M et al.Kerioui M, Beaulieu M, Desmée S, Bertrand J, Mercier F, Jin JY, Bruno R, Guedj J

Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?

2023

DOI

PubMed

Copy reference

JCO precision oncology

Kerioui M et al.Kerioui M, Bertrand J, Desmée S, Le Tourneau C, Mercier F, Bruno R, Guedj J

Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models

2022

DOI

PubMed

Copy reference

British Journal of Clinical Pharmacology

Kerioui M et al.Kerioui M, Bertrand J, Bruno R, Mercier F, Guedj J, Desmée S

Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy

2022

DOI

PubMed

Copy reference

ESMO open

Kerioui M et al.Kerioui M, Desmée S, Mercier F, Lin A, Wu B, Jin JY, Shen X, Le Tourneau C, Bruno R, Guedj J

Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy

2020

DOI

PubMed

Copy reference

Statistics in Medicine

Kerioui M et al.Kerioui M, Mercier F, Bertrand J, Tardivon C, Bruno R, Guedj J, Desmée S

Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment

2020

DOI

PubMed

Copy reference

Journal of Pharmacokinetics and Pharmacodynamics

Mercier F et al.Mercier F, Kerioui M, Desmée S, Guedj J, Krieter O, Bruno R

Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-Up

2019

DOI

PubMed

Copy reference

Clinical Pharmacology and Therapeutics

Tardivon C et al.Tardivon C, Desmée S, Kerioui M, Bruno R, Wu B, Mentré F, Mercier F, Guedj J

Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients

2017

DOI

PubMed

Copy reference

Biometrics

Desmée S et al.Desmée S, Mentré F, Veyrat-Follet C, Sébastien B, Guedj J

Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer

2017

DOI

Copy reference

BMC Med Res Methodol

Desmee S et al.Desmee S, Mentre F, Veyrat-Follet C, Sebastien B, Guedj J

Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches

2015

DOI

PubMed

Copy reference

The AAPS journal

Desmée S et al.Desmée S, Mentré F, Veyrat-Follet C, Guedj J